ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2925 • 2016 ACR/ARHP Annual Meeting

    Programmed Cell Death (PD)-1 May Play a Significant Role in the Pathogenesis of Rheumatoid Arthritis

    Sabina Sandigursky1 and Adam Mor2, 1Medicine, NYU, New York, NY, 2Rheumatology and Pathology, NYU Langone Medical Center, New York, NY

    Background/Purpose: PD-1 is a co-inhibitory transmembrane protein with a significant effect on immune regulation. Several studies have shown elevated expression levels of PD-1 on T…
  • Abstract Number: 2926 • 2016 ACR/ARHP Annual Meeting

    Rorc Positive Th17, Th17/Th1, and Th17.1 Cells from the Blood of Treatment NaïVe RA Patients Differ in IL-17A but Are All Pathogenic When Co-Cultured with RA Synovial Fibroblasts

    Sandra M.J. Paulissen1, Jan Piet van Hamburg2, Nadine Davelaar2, Wendy Dankers3, Patrick Asmawidjaja2, Anne-Marie Otten-Mus2 and Erik Lubberts2, 1Room Nb-84, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands, 2Rheumatology and Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 3Rheumatology, Erasmus MC, University Medical Center, Rotterdam, Netherlands

    Background/Purpose: T cells play a central role in the early stages of rheumatoid arthritis (RA). In this context, we have shown increased proportions of memory…
  • Abstract Number: 2927 • 2016 ACR/ARHP Annual Meeting

    Mechanisms Regulating the Loss of Tregs in CD11c-Flip-KO Mice That Contribute to the Spontaneous Development of Inflammatory Arthritis

    Qi Quan Huang1, Renee E. Doyle2, Robert Birkett1, Deyu Fang3 and Richard M. Pope2, 1Medicine/Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL, 2Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: CD11c-Flip-KO (HUPO) mice spontaneously develop inflammatory, erosive arthritis. We previously demonstrated that T regulatory cells (Tregs) were reduced in HUPO mice and that the…
  • Abstract Number: 2928 • 2016 ACR/ARHP Annual Meeting

    Hypomethylation of an Intragenic Alternative Promoter Contributes to Impaired Treg Function in Rheumatoid Arthritis By Transcriptional Interference with Expression of the Treg-Specific Protein, Glycoprotein a Repetitions Predominant (GARP)

    Alla Skapenko, Jan Leipe and Hendrik Schulze-Koops, Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany

    Background/Purpose:  The expression of Treg specific genes, such as the master transcription factor of Tregs, FoxP3 or the Treg specific surface molecule, glycoprotein A repetitions…
  • Abstract Number: 2929 • 2016 ACR/ARHP Annual Meeting

    The Baseline Th17 Lymphocytes Level Is a Predictive Marker of Good Response to Biologics in Rheumatoid Arthritis

    Sarah Salomon1, Caroline Guignant2, Pierre Morel3, Brigitte Gubler4, Patrice Fardellone5, Jean-Pierre Marolleau6 and Vincent Goeb7, 1Rheumatology, University Hospital of Amiens, Amiens, France, 2Immunology Laboratory, University Hospital of Amiens, Amiens, France, 3Hematology, University Hospital of Amiens, Amiens, France, 4Immunology, University Hospital of Amiens, Amiens, France, 5Department of Rheumatology, Amiens University hospital, Amiens, France, 6hematology, University Hospital of Amiens, Amiens, France, 7Rheumatology, Amiens University Hospital, Amiens, France

    Background/Purpose: In clinical daily practice, the response to biologic drugs is unpredictable in patients with rheumatoid arthritis (RA). Thus, there is a crucial need for…
  • Abstract Number: 2930 • 2016 ACR/ARHP Annual Meeting

    Specific Metabolic and Functional Changes in Peripheral CD8+ T Cells Specifically Distinguish RA from PSA and SPA

    Rui Carvalho1, Christine Tucher2, Lars Tykocinski2, Susanne Neu2, Karel Klika3, H.-M. Lorenz2 and Margarida Souto-Carneiro2, 1Life Sciences Department, FCTUC, Center for Functional Ecology, University of Coimbra, Coimbra, Portugal, 2Rheumatology, Department of Rheumatology, University of Heidelberg, Heidelberg, Germany, 3German Cancer Research Center, Heidelberg, Germany

    Background/Purpose:  Studies by our team and others have shown that CD8 T cells (CD8s) in RA have a pro-inflammatory, cytotoxic effector phenotype and may, therefore,…
  • Abstract Number: 2931 • 2016 ACR/ARHP Annual Meeting

    Endogenous Nur77 Is a Specific Indicator of Antigen Receptor Signaling in Human T and B Cells

    Judith Ashouri and Arthur Weiss, Department of Medicine, Division of Rheumatology, 1Howard Hughes Medical Institute, Rosalind Russell and Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, San Francisco, CA

    D  Intracellular Nur77 protein amounts were assessed by immunofluorescence and flow cytometry in T and B cells isolated from human PBMCs stimulated through their Ag…
  • Abstract Number: 2932 • 2016 ACR/ARHP Annual Meeting

    HLA-DR3 Restricted Response to Lupus-Related Auto-Antigen Smd: Autoreactive T Cells Are Inherent in Normal Immune Repertoires

    Zhenhuan Zhao1, Jiling Ren1, Chao Dai2, Carol Kannapell1, Qian Wang3, Felicia Gaskin4 and Shu Man Fu5, 1Medicine/CIIR/Rheumatology, University of Virginia, Charlottesville, VA, 2Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, VA, 3University of Virginia, Charlottesville, VA, 4Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, 5Department of Medicine, University of Virginia, Charlottesville, VA

    Background/Purpose: HLA class II is the major susceptibility region for systemic lupus erythematosus (SLE) and other autoimmune disorders such as rheumatoid arthritis, multiple sclerosis and…
  • Abstract Number: 2933 • 2016 ACR/ARHP Annual Meeting

    HLA-DR3 Restricted T Cell Response to Smd and Ro60 Reveals Multiple Cross-Reactive Intra- and Inter-Molecular T Cell Epitopes: Unique Antigenic Structures of Lupus-Related Auto-Antigens and the Basis for B Cell Epitope Spreading

    Zhenhuan Zhao1, Jiling Ren1, Chao Dai2, Carol Kannapell1, Qian Wang3, Felicia Gaskin4 and Shu Man Fu5, 1Medicine/CIIR/Rheumatology, University of Virginia, Charlottesville, VA, 2Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, VA, 3University of Virginia, Charlottesville, VA, 4Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, 5Department of Medicine, University of Virginia, Charlottesville, VA

    Background/Purpose:  Complex auto-Abs targeting nuclear proteins is a hallmark of systemic lupus erythematosus (SLE). It is documented that this complexity is the result of “B cell…
  • Abstract Number: 2934 • 2016 ACR/ARHP Annual Meeting

    Clinical Assessment of the Monoclonal Anitbody, PRX003, a Potential Novel Treatment for Th17-Mediated Inflammatory Disease

    Gene G. Kinney1, Kenneth Flanagan1, Michael Skov1, Ronald Goldblum2, Sue Griffith3, Robin M. Barbour1, Wagner Zago1, Ted Yednock1, Martin Koller1 and Dan Ness1, 1Prothena Biosciences Inc, South San Francisco, CA, 2Carlsbad Pharmaceutical Consulting, Inc., Carlsbad, CA, 3ClinPharma Services, Inc, San Diego, CA

    Background/Purpose: Melanoma cell adhesion molecule (MCAM; CD146) is expressed on the surface of Th17 cells, which have the capacity to produce IL-17 and a multitude…
  • Abstract Number: 2935 • 2016 ACR/ARHP Annual Meeting

    Activation Status of Mucosal-Associated Invariant T Cells Sensitively Reflects Disease Activity of Systemic Lupus Erythematosus

    Asako Chiba1, Goh Murayama2, Mie Kitagaichi3, Naoto Tamura4, Ken Yamaji2, Yoshinari Takasaki4 and Sachiko Miyake1, 1Immunology, Juntendo University School of Medicine, Tokyo, Japan, 2Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, 3Department of Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, 4Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan

    Background/Purpose: Mucosal-associated invariant T (MAIT) cells are innate-like lymphocytes that express a semi-invariant TCRα chain: Vα7.2-Jα33 in humans and Vα19-Jα33 in mice. MAIT cells are…
  • Abstract Number: 2936 • 2016 ACR/ARHP Annual Meeting

    All-Trans Retinoic Acid Stabilizes Natural T Regulatory Cells Isolated from Patients with Systemic Lupus Erythematosus Under Inflammatory Conditions

    Julie Wang1, Zixuan Qiao2, Feng Huang3, Ya Liu2, Nancy J. Olsen4 and Song Guo Zheng5, 1Medicine, Penn State Hershey Medical Center, Hershey, PA, 2Medicine, Xuzhou Medical University, Xuzhou, China, 3Center for Clinic Immunology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, Guangzhou, China, 4Medicine/Rheumatology, Penn State Hershey Medical Center, Hershey, PA, 5Medicine/Rheumatology, Penn State University Hershey Medical Center, Hershey, PA

    Background/Purpose: Recent studies have demonstrated that naturally occurring CD4+Foxp3+regulatory T cells (nTregs) are unstable and dysfunctional in the presence of pro-inflammatory cytokines. All-trans RA (atRA),…
  • Abstract Number: 2937 • 2016 ACR/ARHP Annual Meeting

    Regulation of Follicular Helper T (TFH) Cells By ROCK2 (Rho-associated coiled-coil containing protein kinase 2)

    Woelsung Yi1, Sanjay Gupta2, Chien-Huan Weng3, Yurii Chinenov4, James K. Liao5 and Alessandra B. Pernis6, 1Hospital for Special Surgery, New York, NY, 2Autoimmunity & Inflammation Research Program, Hospital for Special Surgery, New York, NY, 3Weill Cornell Medical College, New York, NY, 4Arthritis & Tissue Degeneration Program, Hospital for Special Surgery, New York, NY, 5Cardiology Section, University of Chicago Medical Center, Chicago, IL, 6David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

    Background/Purpose: Follicular helper T (TFH) cells promote humoral responses and serve as a limiting factor for the selection of high affinity germinal center B cells.…
  • Abstract Number: 2938 • 2016 ACR/ARHP Annual Meeting

    U4ATAC Mutation Is Associated with an Immune Dysregulation Syndrome Characterized By Primary Immunodeficiency, Short Stature and Polyglandular Endocrinopathy

    Maria Gutierrez1, Zuoming Deng2, Joshua McElwee3, Richard M. Siegel4 and Eric Hanson5, 1NIAMS, NIH, Bethesda, MD, 2NIAMS/NIH, Bethesda, MD, 3Immunogenetics Genetics and Pharmacogenomics, Merck Research Laboratories, Boston, MA, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, 5National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

    Background/Purpose: A host of primary immunodeficiencies, such as autoimmune polyendocrinopathy, candidiasis, ectodermal dysplasia (APECED), immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX), and STAT5b insufficiency can…
  • Abstract Number: 2939 • 2016 ACR/ARHP Annual Meeting

    Risk of Venous Thromboembolism in Patients with Systemic Vasculitides: A Systematic Review and Meta-Analysis

    Patompong Ungprasert1, Matthew J. Koster2 and Kenneth J. Warrington3, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Rheumatology, University of California Los Angeles, CA, USA Mayo Clinic, Rochester, MN, 3Rheumatology, University of California Los Angeles, CA, USA Mayo, Rochester, MN

    Risk of Venous Thromboembolism in Patients with Systemic Vasculitides: A Systematic Review and Meta-analysis Background/Purpose: Venous thromboembolism (VTE) is a common medical problem with a…
  • « Previous Page
  • 1
  • …
  • 1610
  • 1611
  • 1612
  • 1613
  • 1614
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology